Encoded Therapeutics: Funding, Investors & Team (Oct 2026)
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad range of severe genetic disorders. The company's therapy pipeline addresses devastating genetic and acquired disorders spanning multiple disease pathways including neurocircuitry, metabolic disorders, neurodegeneration and cardiovascular disease, enabling medical practitioners to treat patients and improve their lives.
Encoded Therapeutics has raised $410M across 2 funding rounds on record, the most recent a Series F of $275M announced in Sep 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Encoded Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2026.
Encoded Therapeutics Funding Rounds
Encoded Therapeutics raised $135M in an undisclosed round announced in Jul 2020.
6.2 years later, a Series F of $275M was announced in Sep 2026.
Encoded Therapeutics Investors
20 investors are recorded in total; the 5 named above are those the record identifies.
Encoded Therapeutics Founders and Leadership Team
Contact details for the Encoded Therapeutics team: 3 of 3 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Encoded Therapeutics Funding Compared to Other Biotechnology Startups
Encoded Therapeutics' latest round of $275M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Encoded Therapeutics in Biotechnology and South San Francisco
Companies Similar to Encoded Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Encoded Therapeutics Funding FAQs
What does Encoded Therapeutics do?
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad range of severe genetic disorders. The company's therapy pipeline addresses devastating genetic and acquired disorders spanning multiple disease pathways including neurocircuitry, metabolic disorders, neurodegeneration and cardiovascular disease, enabling medical practitioners to treat patients and improve their lives.
How much funding has Encoded Therapeutics raised?
Encoded Therapeutics has raised $410M across 2 rounds on record. The most recent is a Series F of $275M announced in Sep 2026.
When did Encoded Therapeutics last raise funding?
Encoded Therapeutics' most recent funding round on record is a Series F of $275M, announced in Sep 2026.
Who has invested in Encoded Therapeutics?
Investors on record for Encoded Therapeutics include Menlo Ventures, ARCH Venture Partners, Venrock, Janus Henderson Investors, Invus. FundedIQ records 20 investors in total.
Who founded Encoded Therapeutics?
FundedIQ lists Stephanie Tagliatela (Co-Founder and CSO) at Encoded Therapeutics.
Who is the CEO of Encoded Therapeutics?
Kartik Ramamoorthi is listed as CEO at Encoded Therapeutics.
Where is Encoded Therapeutics headquartered?
Encoded Therapeutics is based in South San Francisco, California, United States.
How many employees does Encoded Therapeutics have?
Encoded Therapeutics is in the 101-250 employee band.
When was Encoded Therapeutics founded?
Encoded Therapeutics was founded in 2014.
How does Encoded Therapeutics' funding compare to other Biotechnology startups?
Encoded Therapeutics' latest round of $275M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Encoded Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Encoded Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.